ANXA3 is upregulated by hypoxia-inducible factor 1-alpha and promotes colon cancer growth

BACKGROUND: Annexin A3 (ANXA3) is overexpressed in various cancers and is a potential target for cancer treatment. However, clinical implication and biological function of ANXA3 in colon cancer remain unknown. This study aimed to investigate the relationship between hypoxia-inducible factor 1-alpha...

Descripción completa

Detalles Bibliográficos
Autores principales: Du, Kunli, Ren, Jiahui, Fu, Zhongxue, Wu, Xingye, Zheng, Jianyong, Li, Xing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797770/
https://www.ncbi.nlm.nih.gov/pubmed/35117344
http://dx.doi.org/10.21037/tcr-20-994

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8797770/
https://www.ncbi.nlm.nih.gov/pubmed/35117344
http://dx.doi.org/10.21037/tcr-20-994

Ejemplares similares